Evidence map›Paper›PMID 24910000›Full record

ArticleFitoterapia2014

Urinary metabolites of isorhynchophylline in rats and their neuroprotective activities in the HT22 cell assay.

Fangfang Chen, Wen Qi, Jiahong Sun, James W Simpkins, Dan Yuan

Abstract read
In one paragraph

Article in Fitoterapia, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
4.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 23 citations in OpenAlex.

  1. Review
  2. The Study of the Transport Mechanism of Isorhynchophylline in Liver.Evidence-based complementary and alternative medicine : eCAM · 2022
    Article
  3. Article
  4. Article
  5. Isorhynchophylline Attenuates MPPNeuromolecular medicine · 2017
    Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Fangfang ChenDepartment of Traditional Chinese Medicines, Shenyang Pharmaceutical University, Shenyang, China.
Wen QiDepartment of Traditional Chinese Medicines, Shenyang Pharmaceutical University, Shenyang, China.
Jiahong SunCenter for Basic and Translational Stroke Research, Department of Physiology and Pharmacology, Robert C. Byrd Health Sciences Center, West Virginia University, Morgantown, WV 26506, United States.
James W SimpkinsCenter for Basic and Translational Stroke Research, Department of Physiology and Pharmacology, Robert C. Byrd Health Sciences Center, West Virginia University, Morgantown, WV 26506, United States.
Dan YuanDepartment of Traditional Chinese Medicines, Shenyang Pharmaceutical University, Shenyang, China. Electronic address: yuandan_kampo@163.com.
Shenyang Pharmaceutical University · CNWest Virginia University · US

Funding

West Virginia IDEA-CTRU54GM104942 · NIGMS · WEST VIRGINIA UNIVERSITY · PI Laura F. Gibson · 2012 to 2026
$81.0M
ROLE OF MITHOCHONDRIAL ERB IN NEURONAL VULNDERABILITY TO NEUROTOXIC STRESSP01AG027956 · NIA · UNIVERSITY OF NORTH TEXAS HLTH SCI CTR · PI SINGH, MEHARVAN · 2007 to 2017
$11.3M
NIA NIH HHS P01 AG027956NIGMS NIH HHS U54 GM104942
6 · The paper itself

Abstract

Isorhynchophylline is one of the major alkaloids from the Uncaria hook possessing the effects of lowered blood pressure, vasodilatation and protection against ischemia-induced neuronal damage. However, the metabolic pathway of isorhynchophylline has not been fully reported yet. In this paper, the metabolism of isorhynchophylline was investigated in rats. Five metabolites were isolated by using solvent extraction and repeated chromatographic methods, and identified by spectroscopic methods including UV, MS, NMR and CD experiments. Three new compounds were identified as 5-oxoisorhynchophyllic acid-22-O-β-D-glucuronide (M1), 17-O-demethyl-16,17-dihydro isorhynchophylline (M2) and 5-oxoisorhynchophyllic acid (M4) together with two known compounds isorhynchophylline (M0) and rhynchophylline (M3). Possible metabolic pathways of isorhynchophylline are proposed. Furthermore, the activity assay for all the metabolites showed that isorhynchophylline (M0) exhibited potent neuroprotective effects against glutamate-induced HT22 cell death. However, little or weak neuroprotective activities were observed for M1-M4. Our present study is important to further understand its metabolic fate and disposition in humans.

Indexed as

AnimalsCell DeathCell LineGlutamic AcidHippocampusIndole AlkaloidsMaleMiceMolecular StructureNeuroprotective AgentsOxindolesRats, WistarGlutamic AcidIndole AlkaloidsNeuroprotective AgentsOxindolesrhyncophyllineHT22 cellIsorhynchophyllineMetabolites from rat urineNeuroprotectionUncaria hook

Identifiers

PMID24910000
PMCPMC4446712
OpenAlexW2030962267

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.